Bertolotti, A
( ad ) Mean (SE) change from baseline in fasting free fatty acids, n = 68 for AMG 133 and n = 6 for placebo at Day 1 (A), fasting triglycerides, n = 6 for AMG 133 and n = 6 for placebo at Day 1 (B), fasting total cholesterol, n = 68 for AMG 133 and n = 6 for placebo at Day 1 (C), fasting LDL, n = 6 for AMG 133 and n = 6 for placebo at Day 1 (D) after multiple ascending doses of AMG 133 or placebo
This article examines the current evidence on GLP-1 and brain fog, explores possible mechanisms, and provides guidance on managing cognitive symptoms while using these medications
In a complementary approach, exenatide-functionalized DFO NPs effectively chelated excess iron and preserved dopaminergic neurons in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model [207]
the studies cited below are phase 1b and phase 2 trials
Tesamorelins potent visceral fat reduction can complement sermorelins broader anti-aging, muscle growth, and GH optimization benefits